Imperial College London
Portrait Picture

DrAilsaHart

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Professor of Practice
 
 
 
//

Contact

 

ailsa.hart

 
 
//

Location

 

Northwick ParkNorthwick Park and St Marks Site

//

Summary

 

Awards

  • Perianal Fistulas - aetiological factors, St Mark's Hospital Foundation, 2012
  • Personalised therapy for IBD, Philip Kirk Charitable Trust, 2012
  • Targeting medical therapy in Crohn's disease, St Mark's Hospital Foundation, 2012
  • Telemedicine in IBD, St Mark's Hospital Foundation, 2012
  • Medical Research Award 2011, Crohn’s and Colitis UK, 2011
  • Anti-TNF pharmacogenomics and IBD genetics in UK south asian population, CORE Digestive Disorders Foundation (part of IBD Genetics Consortium), 2011
  • Gut microbiota and genotype in Crohn's disease, CORE Digestive Disorders Foundation (part of IBD Genetics Consortium), 2011
  • Immunological and Microbiological effects of faecal transplantation in pouchitis, Eil and Edyth Broad Foundation, 2011
  • Interactions between microbial environment, immune system and barrier function in pouchitis, St Mark's Hospital Foundation, 2011
  • Wound Healing in Crohn's disease, ForCrohn's Foundation, 2011
  • Genetics of inflammatory bowel disease, Eranda Foundation, 2010
  • Genetics of inflammatory bowel disease, Mary Kinross Foundation, 2010
  • Immunological assessment of enterocutaneous fistulas, BDRF Research Bursary, 2010
  • Role of homing molecules in IBD, Barden Reserach Foundation, 2010
  • Yakult Europe Immunomodulatory effects by probiotic bacteia on dendritic cells, Yakult Europe, 2010
  • Human gamma delta T cells modulate intestinal immunity in IBD, St Mark's Hospital Foundation, 2009
  • Immunomodulatory role of vitamin D in IBD, St Mark's Hospital Foundation, 2009
  • Microbial assessment of perianal fistulas, St Mark's Hospital Foundation, 2009
  • Modulation of inflammatory effects of leptin in IBD, Eli and Edyth Broad Foundation, 2009
  • Core/IA Research Award, CORE (Digestive Disorders Foundation), 2008
  • Clinical Senior Lecturer Award, Higher Education Council of England (HEFCE), 2008
  • Marie Curie European Grant - Immune homing mechanisms in IBD, Marie Curie European Grant, 2008
  • Proctor and Gamble Award "Immunomodulatory effects of Vitamin D", Proctor and Gamble, 2008
  • PhD Role of dendritic cells in intestinal inflammation and their modulation by probiotic bacteria, Imperial College London, 2005
  • Novartis Foundation Bursary, Novartis, 2003
  • Member of Royal College of Physicians, MRCP London England, 1998
  • Bachelor of Medicine & Surgery achieving George Pickering Prize Proxime Accessit, University of Oxford Clinical School, John Radcliffe Hospital, 1992
  • Merton College Oxford Postmasters Scholarship and book prizes x3 for outstanding achievement, Merton College University of Oxford, 1992
  • BA Hons Class I Physiological sciences University of Oxford, University of Oxford
  • BMA Scholarship, Clinical School, John Radcliffe Hospital, Oxford
  • British Medical and Dental Student Award, Clinical School, John Radcliffe Hospital, Oxford
  • Martin Wronker prize for Medicine for outstanding achievement, University of Oxford
  • Oustanding abstract awards (first author and last author), United European Gastroenterology; British Society of Gastroenterology and European Crohn's and Colitis Organisation 2003 - current (over 20 awards)
  • Peter Tizard Prize for Paediatrics Proxime Accessit, Clinical School, John Radcliffe Hospital, Oxford
  • Research Bursary, BDRF
  • University Psychiatry Prize, Clinical School, John Radcliffe Hospital, Oxford
  • Winner of "Emerging Leaders in Gastroenterology" Competition, Astra Zeneca

External Positions

  • Committee member, Working group for BSG/ HIS national guidelines on faecal microbiota transplantation, British Society of Gastroenterology/ Healthcare Infection Society, 2017 - 2018
  • member, International IBD Connect Programme, International IBD Connect Programme, 2012
  • member/ speaker, International IBD Expert Excahnge Programme, International IBD Expert Excahnge Programme, 2012
  • Member, National IBD Ahead Programme, National IBD Ahead Programme, 2011
  • Deputy Medical Director, St Mark’s Hospital, St Mark’s Hospital, 2011
  • Facult Board Member, Advisory Committee on Clinical Excellence Awards ACCEA, ACCEA, 2009
  • Member, Editor on "Gastrotraining", Editor on "Gastrotraining"
  • Member, Journal Editorial Boards
  • National Inflammatory Bowel Disease Quality Improvement (QIP) and National IBD Audit
  • Member, North West London Hospital Drugs and Therapeutics Committee, North West London Hospital Trust
  • Member, North West Thames IBD Group, St Mary’s Hospital, Hammersmith and Chelsea and Westminster
  • Member, North west Thames CLRN, North west Thames Trust
  • member, Robart's Clinical Trials Europe IBD Network, Robart's Clinical Trials Europe IBD Network
  • member, Sociable Data Programme, Sociable Data Programme
  • Member, Wellcome Trust Case Control Consortium, Wellcome Trust

Membership of Professional Bodies

  • Faculty member of UEG (United European Gastroenterology) Young Investigators' Meeting, United European Gastroenterology, 2013 - 2013
  • Patient and Public Involvement (PPI) Lead for Comprehensive Local Research Network (CLRN), CLRN, 2013
  • Medical Editor, Crohn's and Colitis UK (IBD National patient Charity), 2013
  • Clinical Committee of European Crohn's and Colitis Organisation (one of 5 elected members), ECCO, 2013 - 2015
  • Organising committee for London Inflammatory Bowel disease Forum, London IBD Forum, 2013
  • Gastroenterology Lead for Comprehensive Local Research Network (CLRN) in NW Thames, CLRN, 2012
  • St Mark's Hospital Patient Panel, St Mark's Hospital Patient Panel, 2011
  • London Inflammatory Bowel Disease Interest Group, London IBD Interest Group, 2009
  • Member, American Gastroenterology Association
  • Member, British Medical Association
  • Member, British Society of Gastroenterology
  • Advisory Board for CCUK Strategy for Living with IBD, Crohn's and Colitis UK (IBD National patient Charity)
  • Faculty Member, European Crohn’s and Colitis Organisation
  • Member, Royal College of Physicians
  • Member, St Mark’s Association
  • Lead Consulatnt Organiser of IBD Patient Open Information Day, St Mark's Hospital Patient Panel

Industrial Connections

  • AbbVie, Advisory Board Member
  • AbbVie, Predictors of response to ant-TNF drugs (PANTS study)
  • Abbott Pharmaceuticals, MRI to optimise management of patients with fistulating Crohn’s Disease
  • Abbott Pharmaceuticals, Mechanisms of action of anti-TNF – role of immune cell homing
  • Atlantic, Advisory Board Member
  • BMS, BMS945429 study in Crohn's disease
  • Centocor, Trial of ustekinumab in Crohn's disease
  • CookPharmaceuticals, Perianal fistulating Crohn’s Disease
  • GSK, GSK1605786A trial in Crohn's disease
  • MSD, Advisory Board Member
  • MSD Pharmaceuticals, Predictors of response/non-response to anti-TNF agents
  • Otsuka, ART trial - adacolumn apheresis in UC
  • Oxford Outcomes, Long Term impacts of colectomy surgery among UC patients study
  • Roche, Etrolizumab in UC trial
  • Shire, Advisory Board Member
  • Shire Pharmaceuticals
  • Warner Chilcott, Funding for IBD Specialist Nurse (Transition clinic)
  • Yakult Europe, Immunomodulation by probiotic bacteria via their effects on dendritic antigen presenting cells

Fellowships

  • Wellcome Research Training Fellowship, Wellcome Trust, 2000
  • Glaxo South East Asia Travelling Fellowship, Clinical School, John Radcliffe Hospital, Oxford
  • Wellcome Fellowship Research Training, Wellcome Trust

Editorial Boards

  • Alimentary Pharmacology and Therapeutics, Editorial Board, 2011
  • BMC Gastroenterology, Associate Editor, 2011
  • Medical Editor, Crohn's and Colitis UK (IBD National patient Charity)
  • Editor on "Gastrotraining", Editor on "Gastrotraining"